This protocol is judged by an institutional critique board, an unbiased team that reviews any clinical trials involving humans. If a study includes a Plan I drug, when the board approves the protocol as ethical, the scientists should make an application for an investigational new drug (IND) selection from the FDA.With all the doses packaged and lab